Evidence map›Paper›PMID 27284358›Full record

ArticleOncology letters2016

HER2-positive gastric cancer identified by serum HER2: A case report.

Mayuko Saito, Yujiro Kawakami, Kentaro Yamashita, Hiroshi Nasuno, Y U Ishimine, Koichiro Fukuda, Hiroyuki Isshiki, Ryo Suzuki, Yoshiaki Arimura, Yasuhisa Shinomura

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mayuko SaitoDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Yujiro KawakamiDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Kentaro YamashitaDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Hiroshi NasunoDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Y U IshimineDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Koichiro FukudaDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Hiroyuki IsshikiDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Ryo SuzukiDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Yoshiaki ArimuraDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Yasuhisa ShinomuraDepartment of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University, Sapporo, Hokkaido 060-8543, Japan.
Sapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunohistochemistry (IHC) and fluorescence

Indexed as

false-negativegastric cancerHER2 overexpressionintratumoral heterogeneitysampling errorserum HER2

Identifiers

PMID27284358
PMCPMC4887934
OpenAlexW2342360757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.